Welcome to our dedicated page for Trupanion SEC filings (Ticker: TRUP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trupanion, Inc. (NASDAQ: TRUP) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its business as a provider of medical insurance for cats and dogs. These SEC filings cover areas such as financial performance, risk factors, capital structure, governance, and material agreements that shape the company’s operations and its TRUP stock profile.
Key filings for Trupanion include annual reports on Form 10-K, which describe its subscription and other business segments, geographic reach, insurance entities, and risk considerations; and quarterly reports on Form 10-Q, which update investors on revenue from subscription and other business, enrolled pet counts, net income or loss, cash flows, and technology and development spending. Current reports on Form 8-K disclose material events, such as new credit agreements, earnings releases, and board appointments.
For example, Trupanion has used Form 8-K to report entering into a credit agreement with PNC Bank that provides term loan and revolving credit facilities secured by substantially all of the company’s and certain subsidiaries’ assets, and to announce the appointment of a new independent director to its board. Other 8-K filings reference the issuance of press releases detailing quarterly financial results.
Investors can also review Trupanion’s disclosures on non-GAAP financial measures, forward-looking statements, and risk factors, which are discussed in its periodic reports and referenced in earnings-related filings. These documents explain how the company views metrics such as adjusted EBITDA, net acquisition cost, and cash flow, and outline factors that could affect future performance, including claims trends, retention, regulatory constraints, and capital requirements.
On this page, Stock Titan presents Trupanion’s SEC filings alongside AI-powered summaries that highlight the main points of lengthy documents, such as 10-K and 10-Q reports. Users can quickly identify important information on segment performance, debt arrangements, and governance changes, while still having access to the full text of each filing for deeper review.
Trupanion, Inc. received an amended Schedule 13G/A from Tarmac DLTFM Limited reporting 0 shares beneficially owned of Trupanion common stock, representing 0% of the class. The filing identifies Guernsey as the filer’s citizenship and is dated 02/17/2026; it was signed on 02/25/2026.
TRUPANION, INC. Chief Administration Officer Brenna McGibney reported equity compensation activity, including a new award and vesting of existing restricted stock units. On February 20, 2026, she received a grant of 21,212 restricted stock units (RSUs) that will vest in eighths starting May 22, 2026, then quarterly.
On February 22, 2026, multiple RSU tranches vested and converted into common stock on a one-for-one basis, increasing her direct common stock holdings through derivative exercises. On the same date, 699, 724, and 1,007 common shares were withheld at
TRUPANION, INC. executive Steve Weinrauch, EVP North America & Vet Strategy, reported multiple equity compensation moves. On February 20, 2026, he was granted 12,260 restricted stock units (RSUs), which convert into common stock on a one-for-one basis and vest in eighths starting May 22, 2026, then quarterly, subject to continued service.
On February 22, 2026, previously granted RSUs were exercised and converted into 2,932 and 2,029 shares of common stock. To cover income tax withholding related to these vestings, 869 and 601 shares of common stock were withheld by the company at
Trupanion, Inc. Chief Financial Officer Fawwad Qureshi reported multiple equity compensation transactions involving restricted stock units (RSUs) and common stock. On February 20, 2026, he was granted 35,482 RSUs that vest as to 1/8 of the total on May 22, 2026, then 1/8 quarterly, subject to continued service.
On February 22, 2026, several RSU awards vested and converted into common stock on a one-for-one basis, resulting in acquisitions of common shares at a price of $0.00 per share through derivative exercises. The filing also shows dispositions of 270, 1,467, and 92 common shares at $27.16 per share to satisfy tax withholding obligations in connection with those vestings, which the footnotes state do not represent sales by Qureshi in the open market.
TRUPANION, INC. Chief Legal Officer Asher Bearman reported equity compensation activity and related tax withholding. On February 20, 2026, he was granted 14,656 restricted stock units (RSUs) that vest in eighths beginning May 22, 2026, then quarterly, subject to continued service. On February 22, 2026, previously granted RSUs vested, converting a total of 1,627 RSUs into common stock on a one-for-one basis. To cover income tax obligations, the issuer withheld 609 shares of common stock at $27.16 per share; footnotes state this is not a sale by the reporting person. After these transactions, Bearman directly held 70,290 shares of Trupanion common stock.
Trupanion, Inc. Chief Revenue Officer Emily Dreyer reported equity compensation activity and related tax share withholding. On February 20, 2026, she was granted 10,282 restricted stock units (RSUs), which vest as to 1/8 of the total on May 22, 2026 and then 1/8 quarterly, subject to continued service.
On February 22, 2026, previously granted RSUs converted into 2,249 and 1,340 shares of common stock, and Dreyer acquired the same number of common shares at a price of
Trupanion director Bradley S. Powell reported an equity award vesting and share conversion. On February 22, 2026, 638 restricted stock units (RSUs) vested and were exercised or converted into 638 shares of Trupanion common stock at a stated price of $0.00 per share.
These RSUs come from a grant of 1,906 units awarded on November 14, 2025. According to the grant terms, the award vests and converts into common stock in three equal portions on November 22, 2025, February 22, 2026, and May 22, 2026, subject to Powell’s continued service through each vesting date.
TRUPANION, INC. executive Simon Wheeler, EVP of Trupanion International, reported multiple equity compensation events. On February 20, 2026, he received a grant of 3,079 restricted stock units (RSUs), which vest over time, starting with 1/8 of the total on May 22, 2026 and then quarterly, subject to continued service.
On February 22, 2026, several previously granted RSUs vested and converted on a one-for-one basis into common stock, shown as exercises or conversions of derivative securities. On the same date, a portion of the newly issued shares (440, 717 and 247 shares at a reference price of $27.16) was withheld to cover income tax obligations, which the company states does not represent a sale by Wheeler. After these transactions, Wheeler holds directly owned common stock and remaining RSU balances reflecting ongoing vesting schedules from grants made in 2024, 2025 and 2026.
Trupanion director Howard E. Rubin reported acquiring common shares through restricted stock unit (RSU) vesting. On
These RSUs stem from three grants of 423 units each received on